Combination of irinotecan and a platinum agent for poorly differentiated neuroendocrine carcinomas

Autor: Rodrigo Ramella Munhoz, Juliana Florinda de Mendonca Rego, Anezka Rubim de Celis Ferrari, Maria Ignez Braghiroli, Giovanni Mendonca Bariani, Paulo Marcelo Hoff, Frederico Perego Costa, Tulio Eduardo Flesch Pfiffer, Rachel Riechelmann

Publikováno v: Rare Tumors, Vol 5, Iss 3, Pp e39-e39 (2013)

Extrapulmonary poorly differentiated neuroendocrine carcinoma (PDNEC) is a rare and highly aggressive neoplasm for which the optimal chemotherapy remains unclear. The objective of this study was to evaluate the outcomes of patients with PDNEC treated

Externí odkaz: https://doaj.org/article/c3431cf1b817473a9e320bc54d83be88

Alpha-fetoprotein kinetics in patients with hepatocellular carcinoma receiving ramucirumab or placebo: an analysis of the phase 3 REACH study

Autor: Paolo Abada, Baek Yeol Ryoo, Takuji Okusaka, Jean-Marc Phelip, Etsuro Hatano, Chia Jui Yen, Shinichi Ohkawa, Ronnie T.P. Poon, Tulio Eduardo Flesch Pfiffer, Davide Pastorelli, Jean-Frédéric Blanc, Masatoshi Kudo, Hyun Cheol Chung, Andrew X. Zhu, Ian Chau, Chung Pin Li, Yanzhi Hsu, Joon Oh Park, Katerina Kopeckova, Giovanni Brandi

Publikováno v: British Journal of Cancer

Background Post-hoc analyses of AFP response and progression and their relationship with objective measures of response and survival were performed in patients from REACH. Methods Serum AFP was measured at baseline and every 3 cycles (2 weeks/cycle).

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98ee7a7e5fca1398cdb27776a79a55c6
https://doi.org/10.1038/s41416-018-0103-0

Better Management of Adverse Events Favors Sorafenib Treatment of HCC Patients and Impact on Survival

Autor: Luciana Kikuchi, Paulo M. Hoff, Claudia Megumi Tani, Aline Lopes Chagas, Tulio Eduardo Flesch Pfiffer, Regiane S. S. M. Alencar, Cinira Cintra Camargo, Flair José Carrilho

Publikováno v: Journal of Cancer Therapy. :275-284

Introduction: Sorafenib is an orally active multikinase inhibitor approved for the treatment of advanced hepatocellular carcinoma (HCC) and is the only systemic treatment associated with a survival benefit in advanced stage. The aims of this study we

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f417ad12efa5efcffad4e851fc70839f
https://doi.org/10.4236/jct.2016.74029

Guidelines for the management of neuroendocrine tumours by the Brazilian gastrointestinal tumour group

Autor: Juliana Florinda M. Rego, Raphael Salles Scortegagna de Medeiros, João Evangelista Bezerra Neto, Marcelo Tatit Sapienza, Brenda Gumz, Fabio F. Makdissi, Rui F. Weschenfelder, Marcello D. Bronstein, Paulo Cezar Galvão do Amaral, George Barberio Coura-Filho, Aline Chaves Andrade, Ana Rosa Pinto Quidute, Frederico Costa, Carlos Alberto Buchpiguel, Gustavo Girotto, Duilio Reis da Rocha Filho, Eduardo Linhares Riello Mello, Eduardo A. Fonseca, Tulio Eduardo Flesch Pfiffer, Ana O. Hoff, Nora Manoukian Forones, Marcos Roberto de Menezes, Regis Otaviano Franca Bezerra, Paulo M. Hoff, Bruno dos Santos Vilhena Pereira, Delmar Muniz Lourenço Junior, Ulysses Ribeiro, Maria Candida Barisson Villares Fragoso, Milton Barros, Alessandro Bersch Osvaldt, Ludhmila Abrahão Hajjar, José Cláudio Casali-da-Rocha, Rachel P. Riechelmann, Raphael L. C. Araujo, Allan dos Santos, Renata D'Alpino Peixoto, Gustavo Andrade de Paulo, Joao Glasberg, Anelisa K. Coutinho, Francisco Cesar Carnevale, Maria Adelaide Albergaria Pereira, Luciana Rodrigues de Meirelles, Samuel Aguiar Jr., Fábio Luiz Waechter

Publikováno v: Repositório Institucional da UNIFESP
Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
ecancermedicalscience

Neuroendocrine tumours are a heterogeneous group of diseases with a significant variety of diagnostic tests and treatment modalities. Guidelines were developed by North American and European groups to recommend their best management. However, local p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb2bd3416aca5c0b5a312f8b11de2902
https://repositorio.unifesp.br/handle/11600/55232

I CONSENSO BRASILEIRO DE TRATAMENTO MULTIDISCIPLINAR DE METÁSTASE HEPÁTICA COLORRETAIS MÓDULO 2: MANEJO DAS METÁSTASES RESSECÁVEIS

Autor: Héber Salvador de Castro RIBEIRO, Orlando Jorge Martins TORRES, Márcio Carmona MARQUES, Paulo HERMAN, Antonio Nocchi KALIL, Eduardo de Souza Martins FERNANDES, Fábio Ferreira de OLIVEIRA, Leonaldson dos Santos CASTRO, Rodrigo HANRIOT, Suilane Coelho Ribeiro OLIVEIRA, Marcio Fernando BOFF, Wilson Luiz da COSTA Jr, Roberto de Almeida GIL, Tulio Eduardo Flesch PFIFFER, Fabio Ferrari MAKDISSI, Manoel de Souza ROCHA, Paulo Cezar Galvão do AMARAL, Leonardo Atem Gonçalves de Araújo COSTA, Tomas A. ALOIA, Luiz Augusto Carneiro D'ALBUQUERQUE, Felipe José Fernandez COIMBRA

Publikováno v: ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) v.29 n.1 2016
ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
Colégio Brasileiro de Cirurgia Digestiva (CBCD)
instacron:CBCD
ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo), Volume: 29, Issue: 1, Pages: 13-9, Published: MAR 2016
Arquivos Brasileiros de Cirurgia Digestiva : ABCD
ABCD: Arquivos Brasileiros de Cirurgia Digestiva, Vol 29, Iss 1, Pp 9-13 (2016)

Background : Liver metastases of colorectal cancer are frequent and potentially fatal event in the evolution of patients. Aim : In the second module of this consensus, management of resectable liver metastases was discussed. Method : Concept of synch

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be44aacbf4c97b57ab150260fd8a3678
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-67202016000100009